Jovanovic A, Pekmezovic T, Mesaros S, Novakovic I, Peterlin B, Veselinovic N
Neurol Sci. 2024; 45(9):4463-4469.
PMID: 38594425
DOI: 10.1007/s10072-024-07512-w.
Goodin D, Khankhanian P, Gourraud P, Vince N
PLoS One. 2023; 18(6):e0285599.
PMID: 37379505
PMC: 10306391.
DOI: 10.1371/journal.pone.0285599.
Afrasiabi A, Ahlenstiel C, Swaminathan S, Parnell G
Clin Transl Immunology. 2023; 12(6):e1454.
PMID: 37337612
PMC: 10276892.
DOI: 10.1002/cti2.1454.
Grudziecka Pyrek M, Selmaj K
Front Neurol. 2022; 13:953188.
PMID: 36188381
PMC: 9524155.
DOI: 10.3389/fneur.2022.953188.
Ghimire S, Cady N, Lehman P, Peterson S, Shahi S, Rashid F
Gut Microbes. 2022; 14(1):2127446.
PMID: 36179318
PMC: 9542810.
DOI: 10.1080/19490976.2022.2127446.
Menstrual blood-derived mesenchymal stromal cells efficiently ameliorate experimental autoimmune encephalomyelitis by inhibiting T cell activation in mice.
Li Y, Gao H, Brunner T, Hu X, Yan Y, Liu Y
Stem Cell Res Ther. 2022; 13(1):155.
PMID: 35410627
PMC: 8995916.
DOI: 10.1186/s13287-022-02838-8.
[Twin research in Germany].
Enck P, Goebel-Stengel M, Riess O, Hubener-Schmid J, Kagan K, Niess A
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2021; 64(10):1298-1306.
PMID: 34524474
PMC: 8441034.
DOI: 10.1007/s00103-021-03400-2.
The nature of genetic and environmental susceptibility to multiple sclerosis.
Goodin D, Khankhanian P, Gourraud P, Vince N
PLoS One. 2021; 16(3):e0246157.
PMID: 33750973
PMC: 7984655.
DOI: 10.1371/journal.pone.0246157.
Immune signatures of prodromal multiple sclerosis in monozygotic twins.
Gerdes L, Janoschka C, Eveslage M, Mannig B, Wirth T, Schulte-Mecklenbeck A
Proc Natl Acad Sci U S A. 2020; 117(35):21546-21556.
PMID: 32817525
PMC: 7474627.
DOI: 10.1073/pnas.2003339117.
Breakdown of multiple sclerosis genetics to identify an integrated disease network and potential variant mechanisms.
Shepard C, Cline S, Hinds D, Jahanbakhsh S, Prokop J
Physiol Genomics. 2019; 51(11):562-577.
PMID: 31482761
PMC: 6879814.
DOI: 10.1152/physiolgenomics.00120.2018.
CpG Island Methylation Patterns in Relapsing-Remitting Multiple Sclerosis.
Sokratous M, Dardiotis E, Bellou E, Tsouris Z, Michalopoulou A, Dardioti M
J Mol Neurosci. 2018; 64(3):478-484.
PMID: 29516350
DOI: 10.1007/s12031-018-1046-x.
The Genetics of Multiple Sclerosis: From 0 to 200 in 50 Years.
Baranzini S, Oksenberg J
Trends Genet. 2017; 33(12):960-970.
PMID: 28987266
PMC: 5701819.
DOI: 10.1016/j.tig.2017.09.004.
Deciphering the role of DNA methylation in multiple sclerosis: emerging issues.
Sokratous M, Dardiotis E, Tsouris Z, Bellou E, Michalopoulou A, Siokas V
Auto Immun Highlights. 2016; 7(1):12.
PMID: 27605361
PMC: 5014764.
DOI: 10.1007/s13317-016-0084-z.
HLA-DRB1 the notorious gene in the mosaic of autoimmunity.
Arango M, Perricone C, Kivity S, Cipriano E, Ceccarelli F, Valesini G
Immunol Res. 2016; 65(1):82-98.
PMID: 27435705
DOI: 10.1007/s12026-016-8817-7.
Epigenetic Modifications and Therapy in Multiple Sclerosis.
Aslani S, Jafari N, Javan M, Karami J, Ahmadi M, Jafarnejad M
Neuromolecular Med. 2016; 19(1):11-23.
PMID: 27382982
DOI: 10.1007/s12017-016-8422-x.
Association of EVI5 rs11808092, CD58 rs2300747, and CIITA rs3087456 polymorphisms with multiple sclerosis risk: A meta-analysis.
Liu J, Liu X, Liu Y, Deng S, Huang H, Chen Q
Meta Gene. 2016; 9:97-103.
PMID: 27331013
PMC: 4908284.
DOI: 10.1016/j.mgene.2016.04.005.
Association between seasonal factors and multiple sclerosis.
Watad A, Azrielant S, Soriano A, Bracco D, Much A, Amital H
Eur J Epidemiol. 2016; 31(11):1081-1089.
PMID: 27226079
DOI: 10.1007/s10654-016-0165-3.
The nature of genetic susceptibility to multiple sclerosis: constraining the possibilities.
Goodin D
BMC Neurol. 2016; 16:56.
PMID: 27117889
PMC: 4847201.
DOI: 10.1186/s12883-016-0575-6.
Common and Low Frequency Variants in MERTK Are Independently Associated with Multiple Sclerosis Susceptibility with Discordant Association Dependent upon HLA-DRB1*15:01 Status.
Binder M, Fox A, Merlo D, Johnson L, Giuffrida L, Calvert S
PLoS Genet. 2016; 12(3):e1005853.
PMID: 26990204
PMC: 4798184.
DOI: 10.1371/journal.pgen.1005853.
Genetic evidence for a pathogenic role for the vitamin D3 metabolizing enzyme in multiple sclerosis.
Ramasamy A, Trabzuni D, Forabosco P, Smith C, Walker R, Dillman A
Mult Scler Relat Disord. 2015; 3(2):211-219.
PMID: 25568836
PMC: 4278441.
DOI: 10.1016/j.msard.2013.08.009.